Washington The United States has begun testing anti-malarial drug hydrochloroquine on 2000 people infected with the corona virus ‘covid-19’, which US President Donald Trump has considered a possible cure for corona. The National Institutes of Health (NIH) gave this information in a press release on Friday.
According to the release issued on Thursday, “The patients being tested are found to have infection of SARS-COV-2 virus which is believed to be responsible for Kovid-19 and causing fever, cough and difficulty in breathing. is.” According to the NIH, people participating in this test will be given doses of hydrochloroquine or azithromycin.
HIV-infected patients and pregnant women can also participate in this research. NIH reported that the first participant is from the state of California. In the second phase of this test, the effect of medicines is known, while in the first phase, information about their safety is obtained.
The director of NIH’s Institute of Allergy and Infective Department, Anthony Faukee, said in a release that remodeling of existing drugs is an attractive option as these drugs have undergone extensive testing, which has led to rapid approval of their testing.
The post Trial of anti-malarial drug hydrochloroquine begins in US appeared first on Delhi Up to Date.